tirzepatide vs semaglutide mechanism vs. Tirzepatide: Which GLP-1 Wins? Tirzepatide vs Semaglutide for Weight

Common Side Effects Most side effects are gastrointestinal and typically occur during the titration phase (the first 1620 weeks when your dose is slowly increasing): Very Common: Nausea (affects ~44% of users), diarrhea, vomiting, and constipation

Vigilance on possible hypoglycaemic episodes, especially in patients taking hypoglycaemic drugs, is important

Established Efficacy: Extensive research supports the effectiveness and safety of injectable semaglutide for weight management

Because retatrutide remains investigational, there is no officially published shelf-life or patient-facing storage duration that can be cited for this compound

Behav Brain Res 237: 164171

The most dramatic results typically appear 23 months post-treatment